Fuku Pharmaceutical Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Fuku Pharmaceutical and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 200 Fuku Pharmaceutical employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Fuku Pharmaceutical has purchased the following applications: Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2023, Microsoft 365 for Collaboration in 2023, Amplitude Behavioral Analytics Platform for Marketing Analytics in 2024 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Fuku Pharmaceutical is running and its propensity to invest more and deepen its relationship with Microsoft , Akamai , Cloudflare or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Fuku Pharmaceutical revenues, which have grown to $30.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Fuku Pharmaceutical intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.